Before joining TheStreet.com in August 2008, Woelfel worked as a senior editor at Thomson Financial North America, a division of Thomson Reuters. Prior to that, he was an assignment editor and copy editor at Dow Jones Newswires. He has a bachelor's degree in journalism from Rutgers University in New Brunswick, N.J.
U.S. stock futures decline after Donald Trump says the U.S. will levy 10% tariffs on Sept. 1 on an additional $300 billion of Chinese imports; the U.S. jobs report for July will be released Friday; Exxon Mobil and Chevron report earnings.
U.S. stock futures rise, the day after the Federal Reserve cut interest rates for the first time in more than a decade but Fed Chairman Jerome Powell hinted that future cuts aren't guaranteed; Verizon, GM and DuPont report earnings Thursday; Qualcomm slides on a weak fiscal fourth-quarter forecast.
Burger King will begin selling the Impossible Whopper plant-based burger nationwide for a limited time on Aug. 8.
The cybersecurity company issues weak profit forecasts for the fiscal third quarter and year.
U.S. stock futures rise, getting a lift from Apple, which was higher after the tech giant beat earnings expectations, and as Wall Street prepares for the first interest rate cut from the Federal Reserve in more than a decade; GE, Qualcomm and Humana report earnings.
D.R. Horton says orders in the third quarter rise 6% to 15,588 homes.
U.S. stock futures point lower on Tuesday, the first day of a critical two-day meeting of the Federal Reserve, and ahead of quarterly earnings from tech giant Apple; the earnings calendar also includes reports from Merck, Procter & Gamble, Mastercard and AMD; Capital One says a hacker got access to the personal information of more than 100 million of its credit card customers and applicants.
Amazon.com is in early stage talks to acquire Uber Eats India, according to a report from Business Standard.
U.S. stock futures are mixed as Wall Street prepares for a likely quarter-point rate cut from the Federal Reserve; Beyond Meat reports earnings on Monday; Pfizer will combine its off-patent drugs business with Mylan; Exact Sciences reportedly is in negotiations to buy Genomic Health.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.